B Cells--Tumors clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18 years and up
First-in-human Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-001 given intravenously every 3 weeks.
at UC Davis UCSF
Our lead scientists for B Cells--Tumors research studies include Joseph Tuscano, MD.